A photo of Jenny Hellmann.

Jenny Hellmann, MD


  • Attending Physician, Division of Gastroenterology, Hepatology & Nutrition
  • Assistant Professor, UC Department of Pediatrics
I want the child and the family to thrive. A sick child impacts the entire family, so alleviating the family worry and the burden of the disease is important to me.
Jenny Hellmann, MD

About

Biography

Children make the best patients, and I love seeing them get better and thrive. I chose my specialty area due to the variety of my practice. I work with inpatients and outpatients and also perform procedures. Conditions I treat range from very simple to very complex. I am also involved in quality improvement work.

As a pediatric gastroenterologist, I specialize in pediatric inflammatory bowel disease (IBD) and the treatment of C. difficile infection in children. I want the child and the family to thrive. A sick child impacts the entire family, so alleviating the family worry and the burden of the disease is important to me. Our IBD team is amazing and driven, and our nurses are second to none.

My clinical research centers on the impact of the microbiome in IBD. I also study patterns and processes in care that can be optimized to improve patient outcomes (quality improvement).

When I’m not helping patients, I enjoy spending time with my husband and children more than anything. I also like cooking, ballet and crossword puzzles. I studied Japanese for many years, but I'm pretty rusty!

BSFS: Georgetown University, Washington, DC, 2005.

MD: The Ohio State University, Columbus, OH, 2011.

Residency: Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2014.

Fellowship: Pediatric Gastroenterology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2018.

Certification: General Pediatrics, 2014.

Interests

Pediatric gastroenterology; inflammatory bowel disease; C. difficile infection; fecal microbiota transplant

Services and Specialties

Gastroenterology GI, Inflammatory Bowel Disease IBD

Interests

C.difficile infection in patients with inflammatory bowel disease

Research Areas

Gastroenterology Hepatology and Nutrition

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

Racial Disparities in Pediatric Inflammatory Bowel Disease Care: Differences in Outcomes and Health Service Utilization Between Black and White Children. Smith, J; Liu, C; Beck, A; Fei, L; Brokamp, C; Meryum, S; Whaley, KG; Minar, P; Hellmann, J; Denson, LA; Margolis, P; Dhaliwal, J. The Journal of Pediatrics. 2023; 260:113522.

Su1013 EVALUATION OF INSURANCE TYPE ON PRIOR AUTHORIZATION (PA) DELAYS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS PRESCRIBED BIOLOGIC THERAPIES. Smith, J; Howard, CA; Etter, R; Hellmann, J; Whaley, KG; Minar, PP; Denson, LA; Margolis, P; Dhaliwal, J. Gastroenterology. 2023; 164:s-504-s-505.

Patient-Reported Outcomes Correlate With Microbial Community Composition Independent of Mucosal Inflammation in Pediatric Inflammatory Bowel Disease. Hellmann, J; Ta, A; Ollberding, NJ; Bezold, R; Lake, K; Jackson, K; Dirksing, K; Bonkowski, E; Haslam, DB; Denson, LA. Inflammatory Bowel Diseases. 2023; 29:286-296.

Human iPSC-derived hepatocyte system models cholestasis with tight junction protein 2 deficiency. Li, CZ; Ogawa, H; Ng, SS; Chen, X; Kishimoto, E; Sakabe, K; Fukami, A; Hu, YC; Mayhew, CN; Hellmann, J; Hayashi, H; Thompson, RJ; Rashid, ST; Asai, A. JHEP Reports. 2022; 4:100446.

Neurologic Complications due to Severe Micronutrient Deficiencies in an American Adolescent. Lyles, JL; Hellmann, JA; Oliveira, SB. Nutrition in Clinical Practice. 2021; 36:1059-1062.

Quality Improvement Methodology Optimizes Infliximab Levels in Pediatric Patients with Inflammatory Bowel Disease. Hellmann, J; Etter, RK; Denson, LA; Minar, P; Hill, D; Dykes, DM; Rosen, MJ. Pediatric Quality and Safety. 2021; 6:e400.

Favorable Outcomes and Anti-TNF Durability After Addition of an Immunomodulator for Anti-Drug Antibodies in Pediatric IBD Patients. Colman, RJ; Portocarrero-Castillo, A; Chona, D; Hellmann, J; Minar, P; Rosen, MJ. Inflammatory Bowel Diseases. 2021; 27:507-515.

Effect of a Practice-wide Anti-TNF Proactive Therapeutic Drug Monitoring Program on Outcomes in Pediatric Patients with Inflammatory Bowel Disease. Lyles, JL; Mulgund, AA; Bauman, LE; Su, W; Fei, L; Chona, DL; Sharma, P; Etter, RK; Hellmann, J; Denson, LA; Minar, P; Dykes, DM; Rosen, MJ. Inflammatory Bowel Diseases. 2021; 27:482-492.

A Micro-longitudinal Approach to Measuring Medication Adherence in Pediatric Inflammatory Bowel Diseases. Plevinsky, JM; Denson, LA; Hellmann, J; Minar, P; Rosen, MJ; Hommel, KA. Journal of Pediatric Gastroenterology and Nutrition. 2020; 71:366-370.

Microbial Shifts and Shorter Time to Bowel Resection Surgery Associated with C. difficile in Pediatric Crohn's Disease. Hellmann, J; Andersen, H; Fei, L; Linn, A; Bezold, R; Lake, K; Jackson, K; Meyer, D; Dirksing, K; Bonkowski, E; Ollberding, NJ; Haslam, DB; Denson, L. Inflammatory Bowel Diseases. 2020; 26:1212-1221.

From the Blog

Button Batteries: What Parents Should Know
Blog Healthy Living

Button Batteries: What Parents Should Know

By Jenny Hellmann, MD5/9/2022

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey

4.6
Overall Patient Rating